NeuroPace Wins FDA Approval for AI-Powered Epilepsy Tool
MOUNTAIN VIEW, Calif., May 29, 2026 NeuroPace, Inc., a leading medical technology company focused on transforming the treatment of...
machine learning
Advertisement
Subtle Medical Gains FDA Clearance for SubtleHD PET
MENLO PARK, Calif., May 27, 2026 Subtle Medical, a leading developer of AI-powered medical imaging software, has announced that...
TOBY Gains FDA Breakthrough Status for Alzheimer’s Test
AUSTIN, Texas, May 26, 2026 TOBY, Inc., a biotechnology company focused on non-invasive disease detection technologies, has announced that...
Incyte Expands AI Drug Discovery With Genesis
WILMINGTON, Del. & SAN MATEO, Calif., May 20, 2026 Incyte and Genesis Molecular AI have announced a significant expansion...
Optimi Health Prices $15M Nasdaq Uplisting Offering
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
Advertisements
Paragon Institute Proposes Safer Future for AI Medical Devices
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
Rancho BioSciences Launches OmicsHQ for AI Drug Discovery
SAN DIEGO, Calif., May 19, 2026 Rancho BioSciences has officially launched OmicsHQ™, a comprehensive and expertly curated multi-omics data...
FDA Expands Drug Repurposing Initiative for Rare Diseases
WASHINGTON, May 11, 2026 The U.S. Food and Drug Administration announced a new initiative aimed at accelerating drug repurposing...
Persistent Launches AI Innovation Lab With IIT Kharagpur
Pune, India – May 5, 2026 Persistent Systems has partnered with the Indian Institute of Technology (IIT) Kharagpur to...
Harvard Study Shows AI Outperforms Doctors in Diagnosis
Boston, Massachusetts, United States | April 30, 2026 A new study led by researchers at Harvard Medical School and...
Advertisement
